Table 6.
Blood-lead concentrations range (μg/L) | Benefits | Abatement costs | Net benefits | Hypothetical threshold values (μg/L) | Net cumulated benefits |
---|---|---|---|---|---|
15 ≤ B-Pb < 24 | 1.92 | 0.016 (0.008-0.02) | 1.90 (1) | B-Pb ≥ 15 | 3.78 (1+2+3) |
24 ≤ B-Pb < 100 | 1.64 | 0.016 (0.008-0.02) | 1.63 (2) | B-Pb ≥ 24 | 1.88 (2+3) |
B-Pb ≥ 100 | 0.33 | 0.074 (0.037-0.104) | 0.25 (3) | B-Pb ≥ 100 | 0.25 |
Table 6 presents the net benefits of the removal of lead-based paint in French houses. Lead in soils and dust from the lead-based paint in homes built before 1949 represented 16% and 74% of cases of childhood lead intoxication for B-Pb concentration 15-100 μg/L and for B-Pb concentration≥100 μg/L, respectively. We applied these percentages to calculate the total benefits and the total costs C*paint (with central estimates selected) of the removal of lead-based paint ranged from blood-lead concentrations. We obtained € 1.92 billion(=€11.99billion*16%) and €0.016 billion (=(€0.2453/w30)*16%)) for the 15-24 μg/L range, €1.64 billion (=€10.28*16%) and €0.016 billion (=(€0.2453/w30)*16%)) for the 24-100 μg/L range, and € 0.33 billion (=€ 0.44 billion*74%) and (=(€0.2453/w30)*74%)) for the ≥ 100 μg/L range, respectively. We thus calculated the net benefits of the removal of lead-based paint ranged from blood-lead concentrations: €1.90 billion (1), € 1.63 billion (2) and € 0.25 billion (3) for B-Pb concentration 15-24, 24-100 μg/L and B-Pb concentration≥100 μg/L, respectively. Based on the three hypothetical threshold values, above 15, 24 and 100 μg/L, we estimated also the total net benefit cumulated: €3.78 billions (1+2+3), €1.88 billion (2+3) and €0.25 billion (3), respectively.